News and Announcements
Optiscan Imaging – CEO Interview
- Published October 17, 2012 12:54PM UTC
- Publisher Wholesale Investor
- Categories Executive Interviews
Optiscan is a global leader in the development and application of miniaturised microscopic imaging technologies for medical markets. Optiscan’s imaging technology allows live cellular imaging for earlier and better detection of pre-cancerous and cancerous lesions and more accurate resection during surgery. Optiscan’s technology has been incorporated into Pentax endoscopes since 2006 and will soon be incorporated into the product offering of Carl Zeiss Meditec in neurosurgery and ENT surgery.
Executive Interviews
Why Are Fewer Companies Going Public?
The number of companies listing on the ASX has declined, driven by access to private capital, regulatory burdens, and market volatility. However, public markets still offer liquidity, visibility, and robust capital-raising opportunities.
A Message to Founders: A Shared Journey to 2025 – A Once in a Generation Opportunity
As we close this challenging year, let’s reflect on the resilience, lessons, and growth that brought us here. Founders, 2025 is your golden opportunity to innovate, scale, and thrive. Set your strategy, rest, and prepare to sprint into a year of unparalleled possibilities.
From Trash to Treasure: Inside Australia’s First Commercial Waste-to-Hydrogen Facility
Greenhill Energy’s pioneering waste-to-hydrogen facility marks a significant step in sustainable energy. This Australian innovation is transforming waste management into clean, valuable hydrogen, presenting investors with a unique, forward-thinking opportunity.
Backed By Leading Investment Groups and Family Offices
